Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.86 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.82 |
| ▸ | MEN1 | O00255 | 1/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.80 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.80 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.75 |
| ▸ | GAA | P10253 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | MPO | P05164 | 1/20 | 0.60 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.58 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.58 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.58 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.58 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.58 |
| ▸ | DRD4 | P21917 | 1/20 | 0.57 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.56 |
| ▸ | ADH1B | P00325 | 1/20 | 0.56 |
| ▸ | ADH1C | P00326 | 1/20 | 0.56 |
| ▸ | ADH1A | P07327 | 1/20 | 0.56 |
| ▸ | ADH7 | P40394 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8023026 | 0.97 | CHRM2 (0.86) | MAOACHRM2MEN1KMT2ATDP1 | |
| Hydrochloric Acid SCHEMBL3524869 | 0.97 | MAOA (0.82) | MAOACHRM2MEN1KMT2ATDP1 | |
| Hydrochloric Acid SCHEMBL8021093 | 0.95 | CHRM2 (0.83) | MAOACHRM2MEN1KMT2ATDP1 | |
| SCHEMBL8024796 | 0.95 | CHRM2 (0.91) | MAOACHRM2MEN1KMT2ATDP1 | |
| SCHEMBL12523231 | 0.95 | CHRM2 (0.83) | MAOACHRM2MEN1KMT2ATDP1 | |
| SCHEMBL12523232 | 0.95 | CHRM2 (0.83) | MAOACHRM2MEN1KMT2ATDP1 | |
| SCHEMBL4932707 | 0.95 | MAOA (0.95) | MAOACHRM2MEN1KMT2ATDP1 | |
| SCHEMBL2639857 | 0.93 | CHRM2 (0.95) | MAOACHRM2MEN1KMT2ATDP1 | |
| SCHEMBL7015048 | 0.93 | CHRM2 (0.95) | MAOACHRM2MEN1KMT2ATDP1 | |
| SCHEMBL8025398 | 0.93 | CHRM2 (0.95) | MAOACHRM2MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637439-B2 | Preparation of cannabichromene and related cannabinoids | BAYMEDICA, INC. (US) | 2026-05-26 | — | — | US | claimed |
| US-20230063862-A1 | PREPARATION OF CANNABICHROMENE AND RELATED CANNABINOIDS | BAYMEDICA, INC. | 2023-03-02 | — | — | US | claimed |
| EP-2114899-B1 | CONTROLLED RELEASE OF ACTIVE ALDEHYDES AND KETONES FROM EQUILIBRATED DYNAMIC MIXTURES | FIRMENICH & CIE (CH) | 2010-09-22 | — | — | EP | claimed |
| US-20100098650-A1 | CONTROLLED RELEASE OF ACTIVE ALDEHYDES AND KETONES FROM EQUILIBRATED DYNAMIC MIXTURES | FIRMENICH SA (CH) | 2010-04-22 | — | — | US | claimed |
| EP-2114899-A2 | CONTROLLED RELEASE OF ACTIVE ALDEHYDES AND KETONES FROM EQUILIBRATED DYNAMIC MIXTURES | Firmenich S.A. (CH) | 2009-11-11 | — | — | EP | claimed |
| WO-2008093272-A2 | CONTROLLED RELEASE OF ACTIVE ALDEHYDES AND KETONES FROM EQUILIBRATED DYNAMIC MIXTURES | FIRMENICH SA (CH) | 2008-08-07 | — | — | WO | claimed |
| US-12637439-B2 | Preparation of cannabichromene and related cannabinoids | BAYMEDICA, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| CN-117659017-B | TRPML1/2 modulator compound, pharmaceutical composition, preparation method and application thereof | 北京华益健康药物研究中心 | 2026-05-15 | — | — | CN | disclosed |
| CN-119570023-A | Dynamic polyalkenamine compound and preparation method and application thereof | 华南理工大学 | 2025-03-07 | — | — | CN | disclosed |
| US-12172946-B2 | Compound containing diphenylmethane structure and use thereof | GUANGZHOU TROJAN PHARMATEC LTD. (CN) | 2024-12-24 | — | — | US | disclosed |
| CN-115043867-B | Six-membered cyclic aminosilane external electron donor, preparation method and application thereof | 中国科学院化学研究所 | 2024-11-26 | — | — | CN | disclosed |
| US-20230063862-A1 | PREPARATION OF CANNABICHROMENE AND RELATED CANNABINOIDS | BAYMEDICA, INC. | 2023-03-02 | — | — | US | disclosed |
| CN-115043867-A | Hexa-membered cyclic aminosilane external electron donor, preparation method and application thereof | 中国科学院化学研究所 | 2022-09-13 | — | — | CN | disclosed |
| US-5856590-A | HYDROGENATING 4-T-BUTYLCYCLOHEXANONE BY USING A SPECIFIC RUTHENIUM-PHOSPHINE COMPLEX AS A CATALYST IN THE PRESENCE OF A BASE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1999-01-05 | — | — | US | disclosed |
| US-5750804-A | HYDROGENATING 3-ISOCAMPHYLCYCLOHEXANONE USING RUTHENIUM/PHOSPHINE COMPLEX CATALYST IN PRESENCE OF ALKALI METAL OR ALKALINE EARTH METAL AND AMINE BASE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1998-05-12 | — | — | US | disclosed |
| EP-0829463-A2 | (E)-(R)-2-Alkyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)-2-buten-1-ol, process for preparing the same, and use thereof in perfume compositions | Takasago International Corporation (JP) | 1998-03-18 | — | — | EP | disclosed |
| US-4593098-A | Piperazinone and piperazine polypeptides | THE UPJOHN COMPANY (US) | 1986-06-03 | — | — | US | disclosed |
| US-4534897-A | Piperazinone, piperazine, 1,4-diazepin-2-one and 1,4-diazepine intermediate compounds | THE UPJOHN COMPANY (US) | 1985-08-13 | — | — | US | disclosed |
| US-4251438-A | ANALGESICS, PSYCHOTHERAPEUTIC AGENTS | THE UPJOHN COMPANY (US) | 1981-02-17 | — | — | US | disclosed |
| US-4179469-A | Preparation of amines | UOP INC. (US) | 1979-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637439-B2 | Preparation of cannabichromene and related cannabinoids | CNR2, CNR1, OPRM1 | MAOA 325/4885CHRM2 236/4885MEN1 1301/4885 |
| US-12172946-B2 | Compound containing diphenylmethane structure and use thereof | PEPD, VIP, DNPEP | MAOA 1016/4885CHRM2 4567/4885MEN1 2547/4885 |
| US-20100098650-A1 | CONTROLLED RELEASE OF ACTIVE ALDEHYDES AND KETONES FROM EQUILIBRATED DYNAMIC MIXTURES | PKM, APEH, PLG | MAOA 18/4885CHRM2 589/4885MEN1 4140/4885 |
| US-20230063862-A1 | PREPARATION OF CANNABICHROMENE AND RELATED CANNABINOIDS | CNR2, CNR1, SQLE | MAOA 111/4885CHRM2 1514/4885MEN1 932/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.